OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review
Elham Bahreini, Yousef Rezaei-Chianeh, Mohsen Nabi‐Afjadi
The Review of Diabetic Studies (2021) Vol. 17, Iss. 1, pp. 1-10
Open Access | Times Cited: 23
Elham Bahreini, Yousef Rezaei-Chianeh, Mohsen Nabi‐Afjadi
The Review of Diabetic Studies (2021) Vol. 17, Iss. 1, pp. 1-10
Open Access | Times Cited: 23
Showing 23 citing articles:
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Qi Jin, Tong‐Tong Liu, Yuan Qiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 122
Qi Jin, Tong‐Tong Liu, Yuan Qiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 122
JAK/STAT signaling in diabetic kidney disease
Yingjun Liu, Wenkuan Wang, Jintao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 26
Yingjun Liu, Wenkuan Wang, Jintao Zhang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 26
Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications
Mahyar Ghaffari, Sara Razi, Hamidreza Zalpoor, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 24
Mahyar Ghaffari, Sara Razi, Hamidreza Zalpoor, et al.
Journal of Diabetes Research (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 24
Identification of diagnostic markers related to oxidative stress and inflammatory response in diabetic kidney disease by machine learning algorithms: Evidence from human transcriptomic data and mouse experiments
Ming Zhong, Enyi Zhu, Na Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Ming Zhong, Enyi Zhu, Na Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1029-1052
Open Access | Times Cited: 13
Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1029-1052
Open Access | Times Cited: 13
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 32
Saracatinib, a Src kinase inhibitor, enhances the renoprotective effect of metformin and losartan in diabetic nephropathy
Suzan A Khodir, Eman Sweed, Mona A. Kora, et al.
Archives of Physiology and Biochemistry (2025), pp. 1-16
Closed Access
Suzan A Khodir, Eman Sweed, Mona A. Kora, et al.
Archives of Physiology and Biochemistry (2025), pp. 1-16
Closed Access
Vascular actions of Ang 1-7 and Ang 1-8 through EDRFs and EDHFs in non-diabetes and diabetes mellitus
Nazar M. Shareef Mahmood, Almas M. R. Mahmud, Ismail M. Maulood
Nitric Oxide (2025) Vol. 156, pp. 9-26
Closed Access
Nazar M. Shareef Mahmood, Almas M. R. Mahmud, Ismail M. Maulood
Nitric Oxide (2025) Vol. 156, pp. 9-26
Closed Access
Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy
Manni Rohilla, Rishabh, Seema Bansal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115881-115881
Open Access | Times Cited: 10
Manni Rohilla, Rishabh, Seema Bansal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115881-115881
Open Access | Times Cited: 10
Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease
Annalisa Bianco, Claudio Tiribelli, Cristina Bellarosa
Biomedicines (2022) Vol. 10, Iss. 3, pp. 696-696
Open Access | Times Cited: 13
Annalisa Bianco, Claudio Tiribelli, Cristina Bellarosa
Biomedicines (2022) Vol. 10, Iss. 3, pp. 696-696
Open Access | Times Cited: 13
A Review of the Potential Role of CoQ10 in the Treatment of Hepatocellular Carcinoma
Mahsa Liaghat, Mohammad Yaghoubzad-Maleki, Mohsen Nabi‐Afjadi, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 2, pp. 575-593
Closed Access | Times Cited: 7
Mahsa Liaghat, Mohammad Yaghoubzad-Maleki, Mohsen Nabi‐Afjadi, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 2, pp. 575-593
Closed Access | Times Cited: 7
Renal Expression and Localization of the Receptor for (Pro)renin and Its Ligands in Rodent Models of Diabetes, Metabolic Syndrome, and Age-Dependent Focal and Segmental Glomerulosclerosis
Carla Iacobini, Martina Vitale, Federica Sentinelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2217-2217
Open Access | Times Cited: 2
Carla Iacobini, Martina Vitale, Federica Sentinelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2217-2217
Open Access | Times Cited: 2
Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis
Michelle Yi, Arvin John Toribio, Yusuf Muhammad Salem, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5831-5831
Open Access | Times Cited: 2
Michelle Yi, Arvin John Toribio, Yusuf Muhammad Salem, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5831-5831
Open Access | Times Cited: 2
Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 2
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 2
Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases
Jia Xia, Yan Wan, Jiaojiao Wu, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 5, pp. 1340-1370
Closed Access | Times Cited: 12
Jia Xia, Yan Wan, Jiaojiao Wu, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 5, pp. 1340-1370
Closed Access | Times Cited: 12
The impact of chitooligosaccharides with a certain degree of polymerization on diabetic nephropathic mice and high glucose‐damaged HK ‐2 cells
Y Liu, Ran Zhang, Jiaqi Zou, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 6, pp. 4173-4184
Open Access | Times Cited: 1
Y Liu, Ran Zhang, Jiaqi Zou, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 6, pp. 4173-4184
Open Access | Times Cited: 1
Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway
Dalin Sun, Ziyi Guo, Wenyuan Liu, et al.
Chinese Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 1
Dalin Sun, Ziyi Guo, Wenyuan Liu, et al.
Chinese Journal of Integrative Medicine (2024)
Closed Access | Times Cited: 1
Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience
Mallory L. Downie, Arlene Desjarlais, Nancy Verdin, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access | Times Cited: 2
Mallory L. Downie, Arlene Desjarlais, Nancy Verdin, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access | Times Cited: 2
Studying the Roles of the Renin–Angiotensin System in Accelerating the Disease of High-Fat-Diet-Induced Diabetic Nephropathy in a db/db and ACE2 Double-Gene-Knockout Mouse Model
Cheng‐Yi Chen, M. C. Lin, Xing-Yang Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 329-329
Open Access | Times Cited: 2
Cheng‐Yi Chen, M. C. Lin, Xing-Yang Xie, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 329-329
Open Access | Times Cited: 2
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
Ziyuan Zhang, Yaling Hu, Wenyuan Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2183-2195
Open Access | Times Cited: 4
Ziyuan Zhang, Yaling Hu, Wenyuan Liu, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 2183-2195
Open Access | Times Cited: 4
Overview of the renin-angiotensin system in diabetic nephropathy
Farzaneh Karimi, Maryam Maleki, Ahmad Movahedpour, et al.
Journal of the Renin-Angiotensin-Aldosterone System (2024) Vol. 25
Closed Access
Farzaneh Karimi, Maryam Maleki, Ahmad Movahedpour, et al.
Journal of the Renin-Angiotensin-Aldosterone System (2024) Vol. 25
Closed Access
Water – A life-giving toxin – A nephrological oxymoron. Health consequences of water and sodium balance disorders. A review article
Katarzyna Mitrosz-Gołębiewska, Alicja Rydzewska–Rosołowska, Katarzyna Kakareko, et al.
Advances in Medical Sciences (2021) Vol. 67, Iss. 1, pp. 55-65
Closed Access | Times Cited: 1
Katarzyna Mitrosz-Gołębiewska, Alicja Rydzewska–Rosołowska, Katarzyna Kakareko, et al.
Advances in Medical Sciences (2021) Vol. 67, Iss. 1, pp. 55-65
Closed Access | Times Cited: 1
Renoprotective Effects of Angiotensin-Converting Enzyme Inhibitors (Acei) And/Or Angiotensin Ii Receptor Blockers (Arb) in Diabetic Kidney Disease
Yuting Sun, Ziwei Zhang, Wenjie Sun, et al.
(2023)
Closed Access
Yuting Sun, Ziwei Zhang, Wenjie Sun, et al.
(2023)
Closed Access
